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1. Introduction
  In recent years, studies on the prognosis of critical 
diseases have constituted an important area of critical care 
medicine. It has helped improve medical techniques and 
service, and has greatly reduced medical risks. Among 
them, the acute respiratory distress syndrome (ARDS), which 
was described originally in Lancet in 1967 by Ashbaugh 
DG and coworkers, has remained a focus and difficulty 
in critical care medicine[1]. ARDS is a life threatening 
respiratory failure due to lung injury from a variety of 
precipitants. Pathologically, ARDS is characterized by 
diffuse alveolar damage, alveolar capillary leakage, and 
protein rich pulmonary oedema leading to the clinical 
manifestation of poor lung compliance, severe hypoxemia, 
and bilateral infiltrates on the chest radiograph. It develops 
and progresses rapidly, and its prognosis is bad[2]. Through 
meta-analysis of clinical study literature from 1967 to 
1994 in the international medical community, the mortality 
stayed around 50% for 3 264 ARDS patients[3]. However, 
the ARDS causes 30% to 70% total mortality, which was 
associated with primary illness and illness severity. 
Sepsis and aspiration pneumonia have been associated 
with higher motility, whereas patients with lung injury 
resulting from major trauma have a lower risk of death. 
Direct lung injury has also been associated with greater 
mortality[4]. Elderly patients (over 65 years old) with ARDS 
have a poor prognosis[5]. There were 16% patients die only 
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of respiratory failure, while 49% patients die of the multiple 
organ dysfunction syndrome[6]. Most of ARDS survivors can 
recover completely, but some of them has lung-fibrogenesis 
residue[7]. ARDS can affect many groups of patients and 
is associated with a number of pulmonary and/or extra 
pulmonary factors, which can impact a patient’s prognosis[8]. 
Thus, it is necessary to build a specific criterion or to find 
some biochemical markers to predict ARDS prognosis. 
APACHE 栻 scoring system was regarded as a superior 
biochemical marker to evaluate the outcomes of critically ill 
patients and ill severity[9-14]. Lactate clearance, a surrogate 
for the magnitude and duration of global tissue hypoxia, 
is used diagnostically, therapeutically and prognostically. 
Recent several studies have identified that arterial lactate 
clearance is significantly associated with septic shock 
severity[15-17], and measurement of serum arterial lactate 
clearance is helpful to evaluate pressure of global tissue 
perfusion and to predict patients’ prognosis in serving sepsis 
and septic shock[18-20]. In the current study, we explored 
the easily applicable biochemical markers of practical 
value to evaluate ARDS prognosis through observing acute 
physiological parameters, APACHE 栻 score, alveolar-
arterial oxygen difference, PaO2/FiO2 and arterial blood 
lactate clearance rate. 
2. Materials and methods
2.1. Diagnostic criteria 
  The diagnostic criteria for ARDS (formulated in 1999 
by the chapter of Respiratory Diseases, Chinese Medical 
Association): (i) high risk factors for ARDS; (ii) acute onset 
with tachypnea and (or) respiratory distress; (iii) hypoxemia: 
PaO2/FiO2≤200; (iv) chest X-ray: infiltration shadow 
observed in both lungs; (v) PAWP≤18 mmHg or cardiogenic 
pulmonary edema being clinically excluded.
2.2. Subjects
  72 ARDS patients, who were admitted to the ICUs of 
our hospital from January 2000 to December 2009, were 
registered as the study subjects, among whom 49 died at the 
hospital, 8 were discharged against physician advice and 15 
witnessed improvement in their conditions. The 8 discharges 
against medical advice were counted as subjects in the 
death group of this study, so there were 57 cases in the death 
group, which included 39 males and 18 females with the 
average age standing at 50.75±14.39, and 15 in the survival 
group, which was comprised of 10 males and five females 
with the average age at 49.53±14.01. 
2.3. Analysis methods
  Blood and biochemical tests and blood-gas analyses were 
performed for all subjects upon entry into the ICUs, 12 h, 24 h,
48 h and 72 h after that. Besides, APACHE 栻 scores were 
achieved by combining relevant physiological parameters 
and laboratory results.
2.4. Statistics
  All data achieved were expressed in the manner of (±SD) 
for statistical analysis by the application of SPSS11.0, the 
software for running t-test, Kruskal-Wallis test, linear 
regression analysis and ROC analysis.
3. Results
3.1. APACHE栻 score
  The comparison of APACHE栻 score (t-test) achieved 
at different time frames between the two groups was of 
statistical difference (Table 1). In addition, APACHE栻
score ran in a model of linear regression over time(linear 
regression analysis, R2=0.85) in the death group, meaning 
that APACHE栻 score showed no noticeable improvement or 
even presented a significantly increasing tendency over time 
in the death group despite of active treatments (Figure 1). 
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Figure 1. Linear regression drawn from APACHE 栻 score over time 
in the two groups.
 
3.2. Alveolar-arterial oxygen difference (A-aO2)
  The comparison of A-aO2 (t-test) achieved at different time 
frames between the two groups was of statistical difference 
(Table 2). In addition, A-aO2 value ran in a model of linear 
regression over time (linear regression analysis, R2=0.98) 
in the death group, meaning that A-aO2 value showed no 
noticeable improvement or even presented a significantly 
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increasing tendency over time in the death group despite of 
active treatments. 
3.3. PaO2/FiO2 value
  The comparison of PaO2/FiO2 value (t-test) achieved at the 
time points of 24 h, 48 h and 72 h, respectively, between the 
two groups was of statistical difference (Table 3). In addition, 
PaO2/FiO2 value ran in a model of linear regression over 
time (linear regression analysis, R2=0.95) in the death group, 
meaning that PaO2/FiO2 showed no noticeable improvement 
or even presented a significantly decreasing tendency over 
time in the death group despite of active treatments. 
3.4. Arterial blood lactate clearance rate
  The determination of arterial blood lactate level was started 
only from the year of 2007 at our hospital, thus we have only 
collected such data about 27 patients, consisting of 22 in the 
death group and 5 in the survival group. The comparison of 
arterial blood lactate clearance rate (Kruskal-Wallis test) 
achieved at all the time frames between the two groups was 
of statistical significence (Table 4).
3.5. ROC Curve analysis of APACHE栻 score
  Areas under the ROC curve drawn from APACHE栻 scores 
were 0.919 and 0.955, respectively at 24 h and 72 h upon 
entry into the ICUs, which suggested that it was of noticeable 
significance for the mortality prediction of ARDS patients 
(Figure 2).  
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Figure 2. ROC Curve analysis of APACHE栻 score.
 
3.6. ROC Curve analysis of A-aO2 and PaO2/FiO2
  Areas under the ROC curve of A-aO2 and PaO2/FiO2 value 
after patients’ entering the ICUs ranged from 0.664 to 
0.790 and from 0.242 to 0.351, respectively. Such results 
demonstrated that A-aO2 and PaO2/FiO2, as independent 
Table 1 
Comparison of APACHE栻 score between the 2 groups.
Group Time of admission to hospital 12 h 24 h 48 h 72 h
Survival group 16.47依7.15a 17.13依6.20a 16.93依6.22a   18.6依6.05a 17.07依4.65a
Death group 26.26依7.15 28.04依8.27 30.05依7.14 30.15依7.68 31.67依7.76
aP<0.05 vs. death group.
Table 2
Comparison of A-aO2 value between the 2 groups.
Group  Time of admission to hospital 12 h 24 h 48 h 72 h
Survival group 250.20依81.16a 276.07依108.35a 272.13依107.13a 304.87依129.57a 286.47依171.97a
Death group 323.65依159.13 364.31依143.51 393.88依158.72 431.13依148.61 472.13依141.71
aP<0.05 vs. death group.
Table 3
Comparison of PaO2/FiO2 between the 2 groups.
Group  Time of admission to hospital 12 h 24 h 48 h 72 h
Survival group 157.93依57.48 167.33依98.30 187.20依72.33a 161.87依68.49a 176.27依87.99a
Death group 132.95依96.95 125.12依59.26 115.52依73.01   94.87依43.56   91.41依41.08
aP<0.05 vs. death group.  
Table 4
Comparison of arterial blood lactate clearance rate (%) between the 2 groups.
Group     12 h 24 h 48 h 72 h
Survival group   15.49依9.18a   26.75依16.19a   29.61依16.35a     34.39依29.99a
Death group -29.37依40.39 -31.77依46.05 -57.71依74.19 -109.13依81.98
aP<0.05 vs. death group.
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factors, were neither of notable significance for the mortality 
prediction of ARDS patients.
3.7. ROC Curve analysis of arterial blood lactate clearance 
rate
  Areas under the ROC curve of arterial blood lactate 
clearance rate 12 h, 24 h, 48 h and 72 h after patients’ 
entering the ICUs were 0.918, 0.918, 0.909 and 0.991, 
respectively. Such results demonstrated that A-aO2 and 
PaO2/FiO2 were of marked significance for the mortality 
prediction of ARDS patients (Figure 3).
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Figure 3. ROC Curve analysis of arterial blood lactate clearance rate.
4. Discussion
  ARDS is mainly characterized by alveolar-capillary 
injury, which is the manifestation of acute respiratory 
failure[3,4,8]. The difficulty in its treatment lies in the 
refractory hypoxemia. PaO2/FiO2 value, a major indicator for 
the oxygenating capability of lung, has become a requisite 
for the diagnosis of ARDS. However, PaO2 cannot serve 
as an indicator of tissue cells’ demand and utilization of 
oxygen and is subject to the influence of many factors like 
the concentration of the oxygen inhaled, cardiac output and 
oxygen consumption, etc. A-aO2 represents the difference 
between the oxygen partial pressure in the lung and arterial 
blood, which is related to arteriovenous anatomical shunt, 
ventilation/perfusion imbalance and dysfunction of alveolar-
capillary diffusion barriers, thus bearing better embodiment 
of pulmonary ventilation function[21]. The current study 
suggests that the difference is of statistical significance 
between the two groups in terms of A-aO2 at all the five time 
points. No significantly difference could be found in PaO2/
FiO2 value during the first 24 h upon patients’ entry into 
the ICUs, which may be the result of high concentration of 
inhaled oxygen and unstable hemodynamic. It demonstrates 
that A-aO2 and PaO2/FiO2, as independent factors, is 
neither of notable value for the prognosis of ARDS patients, 
indicating that poor oxygenation constitutes a risk factor of 
poor prognosis but not the only one.  
  APACHE栻 scoring system covers a comprehensive 
multitude of factors like respiration, heart rate, blood 
pressure, consciousness, tissue perfusion and primary 
illnesses. It has been commonly applied both at home and 
abroad in the severity and prognosis assessment of many 
critical illnesses[9-11]. A variety of studies have proven that 
there exists the positive correlation between the APACHE
栻 sore and patients’ mortality[11-14]. The results showed 
that the difference between the two groups was statistically 
significant at all the five time points and the score in the 
death group presents positive correlation with time, which 
means that the score rises accordingly over time. In addition, 
the APACHE栻 scores achieved respectively at 24h and 72h 
after entering the ICUs have been discovered to be of notable 
significance in patients’ prognosis of mortality (measured by 
means of areas under ROC curve, AZ>0.9); the areas under 
ROC curve drawn from APACHE栻 scores were also running 
around 0.9 at other time points we set. To sum up, APACHE栻
score can reflect patients’ disease severity and their response 
to treatments in a timely and accurate manner[21-23].  
  Furthermore, as ARDS takes its course in patients, lactate 
accumulates in patients’ blood stream[24]. This study also 
shows us that statistical difference can be observed in 
terms of patients’ arterial lactate clearance rate over time 
between the two groups and the corresponding areas under 
ROC curve (AZ) were all higher than 0.9, indicating that this 
factor can be validly used to predict patient’s mortality. 
As a result, dynamic monitoring of blood lactate clearance 
rate can be an accurate reflection of tissue perfusion and 
blood oxygenation level after treatment, and thus it helps 
to make an effective and objective assessment of patients’ 
prognosis[18-20,25]. The prognosis can be more accurately 
assessed as long as dynamic monitoring of blood lactate 
clearance rate is performed in combination with APACHE栻 
scoring.
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